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Abstract 
Bovine tryptophanyl-tRNA synthetase (TrpRS, E.C. 6.1.1.2) isunable to catalyze in vitro formation of Ap4A in contrast to some other aminoacyl- 
tRNA synthetases. However, in the presence of L-tryptophan, ATP-Mg 2÷ and ADP the enzyme catalyzes the Ap3A synthesis via adenylate 
intermediate. Ap3A (not Ap4A) may serve as a substrate for TrpRS in the reaction of E. (Trp ~ AMP) formation and in the tRNA Tw charging. The 
Km value for Ap3A was higher than the Km for ATP (approx. 1.00 vs. 0.22 mM) and Vm~x was 3 times lower than for ATP. The Zn2+-deficient zyme 
catalyzes Ap3A synthesis nthe absence of exogenous ADP due to ATPase activity of Zn2+-deprived TrpRS. The inability of mammalian TrpRS to 
synthesize Ap4A, might be considered as a molecular tool preventing the removal of Zn 2÷ due to chelation by Ap4A and therefore preserving the 
enzyme activity. 
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1. Introduction 
Ap3A and Ap4A known since mid-1960s, are wide- 
spread in living cells (see [1,2] and references therein). 
These ubiquitous cell compounds belong to the family 
with a general formula Ap4N or Ap3N, where N is one 
of the purine or pyrimidine nucleosides. ApaA/Ap3 A 
seem to be implicated in cell metabolic pathways [3,4]. 
The ability to catalyze ApnA and Ap3A synthesis was 
first reported for lysyl-tRNA synthetase from E. coli [5]. 
Later some other aaRS of different origin and amino 
acid specificity were shown to synthesize such dinucleo- 
side oligophosphates in vitro (see [3]). It was suggested 
that these aaRS are also able to catalyze in vivo Ap4A 
and Ap3A synthesis. ApnA synthesis catalyzed by these 
aaRS proceeds through the stage of the aminoacyl 
adenylate, nzyme complex formation [6,7] as 
does the synthesis of aminoacyl - tRNA.  At the same time, 
these enzymes are able to utilize at least in vitro [4] Ap4A 
for the formation of aminoacyl adenylate. Besides Ap4A 
synthesis, Ap3A formation was reported for the same 
enzymes from the adenylate.enzyme complexes where 
ADP was generated in the process of Ap4A hydrolysis 
[6,7]. No aaRS exhibited Ap3A synthesis independent 
from Ap4 A formation. 
AaRS of different amino acid specificities are subdi- 
vided into three groups with respect to their ability to 
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form Ap4A [6]. TrpRS is placed with the aaRS showing 
no significant rate of Ap4A synthesis. Here we report 
that TrpRS is able to catalyze the in vitro synthesis of 
Ap3A. Part of these results has been published else- 
where [8]. Furthermore, we found out that TrpRS is also 
able to use Ap3A (not Ap4A) instead of ATP in the 
reactions ofE.  (Trp - AMP)  formation and tRNA xrp ami- 
noacylation. 
2. Experimental 
TrpRS was purified from the bovine pancreas as described earlier 
[9,10]. Two types of enzyme preparations were used: (i) the preparations 
containing one Zn 2+ atom per dimeric molecule isolated in the absence 
of EDTA [9] and (ii) Zn:+-deprived preparations isolated either after 
addition of EDTA or after prolonged storage [10]. The latter samples 
possessed lower enzymatic a tivity and were able to hydrolyse ATP into 
ADP and P~ [l 1]. As tested by the denaturing polyacrylamide g lelec- 
trophoresis, both enzyme forms were homogeneous. Both preparations 
posssessed no Ap4A-pyrophospho ydrolysing activity: labelled ADP, 
or ATP and AMP have been not detected after incubation of the 
enzyme with [3H]Ap4A. 
Ap3A synthesis was examined in two ways. First, tryptopha- 
nyl[~4C]adenylate.TrpRS complex was obtained and isolated as 
described [9] and treated with the excess of ADP (see legend to 
Fig. 2). In the second assay, the sample initially contained ADP 
and all the components needed for the formation of the trypto- 
phanyl[~4C]adenylate . enzyme complex in situ [9]. ATP/E and ATP/ADP 
ratios in the incubation mixtures varied from 100:1 to l:l mol/mol. 
The reaction products were identified on the PEI-cellulose plates 
(Merck, Germany). Aliquots of the reaction mixture were applied to- 
gether with the nucleotide markers. The plates were washed with H20 
and than dried and developed in0.75 M LiCl, or in 0.75 M KH2PO 4 
(pH 3.5), or in 0.8 M LiCl + 7% H3BO 3 (pH 4.6). The nucleotide 
derivatives were detected in UV light and fluorographed. In order to 
estimate the amounts of the labelled nucleotides, the corresponding 
areas of PEI-cellulose plates were removed and counted in the toluene 
scintillation liquid on SL-30 (Intertechnique, France) counter. 
E. (Trp ~ AMP) formation from [14C]tryptophan and Ap3A was meas- 
ured by the retention of t4C-label of aminoacyl adenylate, nzyme com- 
plexes absorbed on BA83 nitrocellulose filters. 
HPLC was performed on the 0.4 x 15 cm Shandon APC (UK) col- 
umn. Nucleotides were eluted by the linear gradient of KH2PO 4 
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Fig. 3. Ap3A synthesis atthe conditions of E. (Trp ~ AMP) formation 
catalyzed by enzyme preparations with Zn/E ratio = 1 mol/mol of 
dimer in the presence ofADP (a), and with Zn/E = 0.6 mol/mol of 
dimer in the absence of ADP (b). (D) -ATE (¢) -Ap3A, (A) -AMP, 
(-) -ADE Concentration f the reagents: [14C]ATP, 0.1 raM; trypto- 
phan, 5 x l0 -5 M; MgCl2, 8 mM; KCI, 150 mM; DTT, 0.1 raM; inor- 
ganic pyrophosphatase, 0.015 mg/ml; ADP, 1 mM. Incubation at37°C, 
pH 7.5. 
inorganic pyrophosphatase. As seen from Fig. 3A, the 
decrease of ATP concentration and increase of AMP 
concentration are accompanied by Ap3A synthesis and 
de novo ADP formation. The curve of Ap3A synthesis 
reaches a maximum after 3 h. The complex pattern of 
Ap3A synthesis, as well as the elevated levels of AMP and 
ADP in the reaction mixture seem to indicate that after 
the decrease of ATP concentration Ap3A takes part in 
the E" (Trp~AMP) synthesis as considered in the section 3.1. 
Fig. 3b shows the kinetics of the Ap3A formation cat- 
alyzed by Zn2*-depleted TrpRS in the absence of ex- 
ogenous ADP. In this case, Ap3A synthesis may be re- 
lated to the ADP formation caused by ATP hydrolysis 
catalyzed by Zn2+-deprived nzyme [10]. The curve (Fig. 
3a,b) has an incline at half of the initial ATP concentra- 
tion. Probably, when E" (Trp - AMP) complex is formed 
in situ, its interaction with ADP induces negative cooper- 
ativity for the two enzyme subunits as described earlier 
for the other low-molecular-weight ligands [9]. 
3.3. TrpRS is deficient in Ap4A-synthetase activity 
The lack of ApaA synthesis by TrpRS [6] might be in 
principle connected with the non-optimal experimental 
conditions chosen for its detection. Therefore, we de- 
cided to examine Ap4A-synthetase activity of TrpRS at 
variable concentrations of TrpRS ( 1-10/JM), ATP ( 1 - 10 
mM) and tryptophan (10-2-1 mM). The effect of Mg 2+ 
(1-10 raM), Mn 2+ (0.1-1.0 mM) and inorganic pyro- 
phosphatase (0.015 mg/ml) on Ap4 A synthesis was also 
studied. TLC showed no Ap4A formation for up to 17 
h incubation in all these assay conditions. Furthermore, 
no Ap4A formation was noticed after incubation of 
E. (Trp - AMP) with ATP (data not shown). 
In order to check the possibility of amino acid-inde- 
pendent but AMP-dependent Ap4A synthesis described 
earlier for the lysyl-tRNA synthetase from rat liver [13] 
we studied the effect of AMP concentration (2-10 mM) 
on the reaction rate. Stimulation of Ap4A synthesis was 
recorded neither in the presence, nor in the absence of 
tryptophan (data not shown). 
Consequently, TrpRS in fact does not catalyze Ap4A 
synthesis in accord with the earlier data [6]. 
4. Discussion 
Contrary to the majority of the aaRS, mammalian 
TrpRS in a wide range of the reaction conditions is una- 
ble to catalyze Ap4A synthesis. This property of TrpRS 
may be related to the fact that PPi split off ATP in the 
course of T rp -  AMP synthesis on the enzyme remains 
tightly bound to the TrpRS [14]. The bound PPi is non- 
hydrolyzable by inorganic pyrophosphatase [15]. When 
PPi and Trp - AMP are both bound to the same enzyme 
molecule, further binding of ATP molecule is precluded 
(see [15]); that accounts for the inability of TrpRS to pro- 
mote Ap4A formation. Furthermore, contrary to the ma- 
jority of the aaRS, TrpRS is virtually unable to utilize Ap4A 
instead of ATP in tRNA Trp aminoacylation reaction. 
For Ap4A-synthesyzing aaRS, Ap3 A synthesis i a sec- 
ondary process: aminoacyl adenylate.enzyme complexes 
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react with ADP generated in prokaryotes from Ap4A 
degradation to2 ADP (see [2,6] and references therein). 
Therefore, as TrpRS does not promote Ap4 A synthesis 
it is unable to synthesize Ap3A through Ap4 A decompo- 
sition. 
Nevertheless, as shown here TrpRS is able to utilize 
Ap3A instead of ATP as a substrate for the reactions of 
E. (Trp - AMP) formation and tRNA xrp aminoacylation, 
and to catalyze at certain conditions the Ap3A synthesis 
as well. This Ap3A-synthetase activity of the TrpRS is 
related neither to the presence of traces of ATP in the 
reaction mixture, nor to the contaminating pyrophospho 
hydrolase activity. 
Lower stoichiometry for Trp-  AMPLE observed for 
Ap3A as compared with ATP could be caused by at least 
two factors: (i) E-(Trp- AMP) formed from Ap3 A ap- 
pears to be less stable because it is known (see [14] and 
references therein) that aminoacyl adenylate.enzyme 
complexes are stabilized by the additional binding of PPi 
from ATP; in case of Ap3A the second product of the 
reaction is ADP, not PPi; (ii) the second adenosine moi- 
ety present in Ap3A molecule might generate stereo- 
chemical hindrance in the course of Ap3A reaction with 
tryptophan. 
In the tRNA Trp aminoacylation reaction, K m for Ap3A 
is almost he same as Ks for ATE but is twice higher than 
Km for ATP in the same reaction [9]. The maximal reac- 
tion rate (Vmax) for Ap3A is about 113 of Vm,x for ATE 
This difference may be related to the difference of the 
reaction products (PPi in the case of ATP and ADP in 
the case of Ap3A): it is known that ADP is a TrpRS 
inhibitor non-competitive with ATP [16]. 
TrpRS catalyzes Ap3 A synthesis when ADP is added 
to the isolated E. (Trp - AMP) and also at the conditions 
of in situ formation of E. (Trp - AMP) in the presence of 
10-fold molar excess of ADP over ATE Consequently, 
Ap3A synthesis proceeds via aminoacyl adenylate inter- 
mediate. This conclusion agrees with the dependence of
this reaction on the presence of L-tryptophan, ATP-Mg 2+ 
and inorganic pyrophosphatase. 
The adenylate pathway of the Ap3A synthesis might 
be expected a priori: from the fact that Ap3A may serve 
as a substrate for the reaction of E- (Trp - AMP) forma- 
tion it follows that the reversed reaction of E.(Trp- 
AMP) with ADP is eligible according to the principle of 
micro reversibility of chemical reactions. Therefore, 
Ap3A may be regarded as both a substrate and a product 
of one of the non-canonical reactions catalyzed by TrpRS. 
Ap3 A synthesis from E.(Trp-AMP) was observed 
both in the presence and in the absence of exogenous 
ADP for the Zn2+-deprived TrpRS preparations (Zn2+/ 
E < 0.6 mol/mol per dimer). Recently, ATPase/GTPase 
activity of Zn2+-depleted nzyme preparations was de- 
scribed [10]. These preparations were unable to form 
E.(Trp-AMP) [10]. The reaction of Ap3A for- 
mation by the Zn2+-deprived nzyme seems to proceed 
as follows. The preparations contain two types of mole- 
cules, and consequently the molecules with normal 
Zn 2+ content (Zn/E about 1 mol/mol) are able to form 
E-(Trp- AMP), whereas the enzyme molecules lacking 
Zn z+ are able to catalyze ATP hydrolysis. The reaction 
of ADP formed from ATP with E. (Trp - AMP) leads to 
the accumulation of Ap3A as a final product. 
The ability of mammalian TrpRS to catalyze the syn- 
thesis of Ap3A, not Ap4A, might be considered as a 
molecular tool preventing the enzyme inactivation. 
Ap4 A, known to be a strong chelator for the Me 2+ ions 
[17] may chelate Zn 2+ ion essential for the enzymatic 
activity [11] and remove it from the enzyme [15]. 
If this is the case, the enzymes actively forming Ap4A 
should not require Me 2+ for their activity. In fact, aaRS 
of this type either contain no Zn 2+, or Zn 2+ ion is not 
essential for their catalytic activity [18]. Contrary to 
Ap4 A, Ap3A is not a strong chelator of Me 2÷, and conse- 
quently does not affect the aminoacylation function of 
TrpRS. Ap3A is often regarded as physiological ntago- 
nist of Ap4A (see [3,19] and references therein). We 
assume that Ap4A-synthesyzing (Lys, Pro, etc.) and 
Ap3A-synthesyzing (Trp) enzymes might be implicated in 
regulation of Ap3A/Ap4A ratio in the cells. 
References 
[1] Rapaport, E. and Zamecnik, P.C. (1976) Proc. Natl. Acad. Sci. 
USA 73, 3984-3988. 
[2] Guranovski, A., Starzynska, E. and Wasternack, C. (1988) Int. J. 
Biochem. 20, 449-455. 
[3] Zamecnik, E (1983) Anal. Biochem. 134, l 10. 
[4] Remy, P. (1992) in: Ap4 A and other dinucleoside phosphates 
(McLennan, A.G., Ed.) p. 368, CRC Press, Boca Raton, F.L. 
[5] Zamecnik, EC., Stephenson, M.L., Janeway, C.M. and 
Randerath, K. (1966) Biochim. Biophys. Res. Communs. 24, 
91 97. 
[6] Goerlich, O., Foekler, R. and Holler, E. (1982) Eur. J. Biochem. 
126, 135 142. 
[7] Mayaux, J.-P. and Blanquet, S. (1981) Biochemistry 20, 4647 4654. 
[8] Kovaleva, G., Merkulova, T. and Kisselev, L. (1988) Dokl. Acad. 
Nauk. SSSR 301, 1501-1504. 
[9] Kisselev, L., Favorova, O. and Kovaleva, G. (1979) Methods 
Enzymol. 59, part G, 234-257. 
[10] Kovaleva, G., Nikitushkina, T. and Kisselev, L. (1993) FEBS Lett. 
335, 198 202. 
[11] Kisselev, L., Favorova, O., Nurbekov, M., Dmitrienko, S. and 
Engelhardt, W. (1981) Eur. J. Biochem. 120, 511-517. 
[12] Tarussova, N., Zavgorodny, C. and Ossipova, T. (1985) Bioorg. 
Chim. (Moscow) 11,802-807. 
[13] Hilderman, R.H. (1983) Biochemistry 22, 4353-4357. 
[14] Kovaleva, G., Holmuratov, E. and Kisselev, L. (1983) FEBS Lett. 
151, 79 82. 
[15] Kisselev, L. and Kovaleva, G. (1987) Sov. Sci. Rev. D. Physico- 
chem. Biol. (V. Skulachev, Ed.) 7, 137 186. 
[16] Nevinsky, G.A., Lavrik, O.I., Favorova, O.O. and Kisselev, L.L. 
(1979) Bioorg. Chim. (Moscow) 5, 352-364. 
[17] Holler, E.., Holmquist, B., Vallee, B.L., Taneja, K. and Zamecnik, 
P. (1983) Biochemistry 22, 49244933. 
[18] Carter, C.W. (1993) Annu. Rev. Biochem. 62, 715 748. 
[19] Guranovsky, A. and Blanquet, S. (1985) J. Biol. Chem. 260, 3542 
3547. 
